• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Health wearable devices effectively promote bodyweight in overweight/obese individuals

byMinjee Kim
September 8, 2021
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter
  1. Use of accelerometer/pedometer-only and commercial health wearable-only were the most effective at reducing body weight in comparison with the other groups.
  2. Multicomponent accelerometer/pedometer and commercial health wearable-only interventions were the most effective at reducing body mass index in comparison to the other groups.

Evidence Rating Level: 1 (Excellent)

Being overweight remains a significant public health challenge, of which physical inactivity is a major contributor. Physical activity wearables have the potential to encourage physical activity; however, there is a lack of evidence pointing to the most effective method. As a result, the goal of this study was to perform a systemic review of randomized controlled trials (RCTs) investigating the effect of health wearable-based physical activity interventions on body mass index (BMI) and bodyweight reduction in overweight/obese individuals with chronic health conditions.

Of 641 screened records, 31 studies (2268 patients) from December 2019 to September 2020 were included in the analysis. Included studies met the following criteria: participants were overweight/obese and/or had at least one chronic comorbidity and studied the effect of health-wearable interventions on weight or BMI. The six comparison groups included four wearable interventions, one comparison group (non-health wearable physical activity) and control group (usual care, waitlist). Network geometry and network meta-analysis were used to compare the effect of each intervention on the primary outcome.

Results stated that the commercial health-wearable only and the accelerometer/pedometer-only groups were most effective at reducing bodyweight compared with the control. With respect to BMI reduction, commercial health wearable-only and multicomponent accelerometer/pedometer interventions were found to be most effective. One of the key strengths of this study was its use of strict criteria which allowed for a homogenous sample. However, due to insufficient direct comparisons available to assess BMI reduction, the results for this outcome must be interpreted with caution. As a whole, these results suggest that the use of health wearable-based physical activity interventions may help achieve modest bodyweight and/or BMI reductions.

Click to read the study in British Journal of Sports Medicine

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk

Association between baseline BMI and in-hospital mortality in critically ill cardiac surgery patients: a retrospective cohort study

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

Tags: #Accelerometer#Fitbit#Health WearablesBMIbody mass indexbody weightdevicenutritionobeseobesityoverweightpedometerweight loss
Previous Post

Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada

Next Post

#VisualAbstract: Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa

RelatedReports

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk

November 23, 2025
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Cardiology

Association between baseline BMI and in-hospital mortality in critically ill cardiac surgery patients: a retrospective cohort study

November 17, 2025
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Chronic Disease

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

October 29, 2025
Many new pediatric asthma cases attributable to obesity
Chronic Disease

Effect of short-term exercise with different programs on prevention of sarcopenia in postmenopausal women: A Quasi-Randomized Controlled Trial

October 6, 2025
Next Post
#VisualAbstract: Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa

#VisualAbstract: Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa

#VisualAbstract: Trastuzumab emtansine monotherapy is noninferior to standard neoadjuvant therapy for ERBB2+ breast cancer

#VisualAbstract: Trastuzumab emtansine monotherapy is noninferior to standard neoadjuvant therapy for ERBB2+ breast cancer

Updated USPSTF guidelines favor treatment of mild gestational diabetes

Novel macrophage-regulating cream demonstrated superior therapeutic efficacy for the treatment of diabetic foot ulcers compared to standard absorbent dressing

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Comparison of two different bicarbonate replacement fluids during CVVH with RCA: a prospective, randomized, controlled trial
  • Age-Based Screening for Lung Cancer Surveillance in the US
  • Prehospital Postintubation Hypotension and Survival in Severe Traumatic Brain Injury
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.